These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 11170098)

  • 1. Tay-Sachs screening in the Jewish Ashkenazi population: DNA testing is the preferred procedure.
    Bach G; Tomczak J; Risch N; Ekstein J
    Am J Med Genet; 2001 Feb; 99(1):70-5. PubMed ID: 11170098
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rapid nonradioactive tracer method for detecting carriers of the major Ashkenazi Jewish Tay-Sachs disease mutations.
    Strasberg PM; Clarke JT
    Clin Chem; 1992 Nov; 38(11):2249-55. PubMed ID: 1424119
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Screening for carriers of Tay-Sachs disease in the ultraorthodox Ashkenazi Jewish community in Israel.
    Broide E; Zeigler M; Eckstein J; Bach G
    Am J Med Genet; 1993 Aug; 47(2):213-5. PubMed ID: 8213907
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Population-specific screening by mutation analysis for diseases frequent in Ashkenazi Jews.
    DeMarchi JM; Caskey CT; Richards CS
    Hum Mutat; 1996; 8(2):116-25. PubMed ID: 8844209
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification and rapid detection of three Tay-Sachs mutations in the Moroccan Jewish population.
    Drucker L; Proia RL; Navon R
    Am J Hum Genet; 1992 Aug; 51(2):371-7. PubMed ID: 1322637
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of enzyme and DNA analysis in a Tay-Sachs disease carrier screening program.
    Yoo HW; Astrin KH; Desnick RJ
    J Korean Med Sci; 1993 Feb; 8(1):84-91. PubMed ID: 8343225
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Frequency of the Tay-Sachs disease splice and insertion mutations in the UK Ashkenazi Jewish population.
    Landels EC; Ellis IH; Fensom AH; Green PM; Bobrow M
    J Med Genet; 1991 Mar; 28(3):177-80. PubMed ID: 1828838
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Population-based Tay-Sachs screening among Ashkenazi Jewish young adults in the 21st century: Hexosaminidase A enzyme assay is essential for accurate testing.
    Schneider A; Nakagawa S; Keep R; Dorsainville D; Charrow J; Aleck K; Hoffman J; Minkoff S; Finegold D; Sun W; Spencer A; Lebow J; Zhan J; Apfelroth S; Schreiber-Agus N; Gross S
    Am J Med Genet A; 2009 Nov; 149A(11):2444-7. PubMed ID: 19876898
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tay-Sachs disease and HEXA mutations among Moroccan Jews.
    Kaufman M; Grinshpun-Cohen J; Karpati M; Peleg L; Goldman B; Akstein E; Adam A; Navon R
    Hum Mutat; 1997; 10(4):295-300. PubMed ID: 9338583
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Heterozygote screening for Tay-Sachs disease: past successes and future challenges.
    Natowicz MR; Prence EM
    Curr Opin Pediatr; 1996 Dec; 8(6):625-9. PubMed ID: 9018448
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The frequency of Tay-Sachs disease causing mutations in the Brazilian Jewish population justifies a carrier screening program.
    Rozenberg R; Pereira Lda V
    Sao Paulo Med J; 2001 Jul; 119(4):146-9. PubMed ID: 11500789
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The major defect in Ashkenazi Jews with Tay-Sachs disease is an insertion in the gene for the alpha-chain of beta-hexosaminidase.
    Myerowitz R; Costigan FC
    J Biol Chem; 1988 Dec; 263(35):18587-9. PubMed ID: 2848800
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biallelic discrimination assays for the three common Ashkenazi Jewish mutations and a common non-Jewish mutation, in Tay-Sachs disease, using fluorogenic TaqMan probes.
    Ward CP; Fensom AH; Green PM
    Genet Test; 2000; 4(4):351-8. PubMed ID: 11216658
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Origin and spread of the 1278insTATC mutation causing Tay-Sachs disease in Ashkenazi Jews: genetic drift as a robust and parsimonious hypothesis.
    Frisch A; Colombo R; Michaelovsky E; Karpati M; Goldman B; Peleg L
    Hum Genet; 2004 Mar; 114(4):366-76. PubMed ID: 14727180
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel mutations and DNA-based screening in non-Jewish carriers of Tay-Sachs disease.
    Akerman BR; Natowicz MR; Kaback MM; Loyer M; Campeau E; Gravel RA
    Am J Hum Genet; 1997 May; 60(5):1099-106. PubMed ID: 9150157
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Beta-hexosaminidase splice site mutation has a high frequency among non-Jewish Tay-Sachs disease carriers from the British Isles.
    Landels EC; Green PM; Ellis IH; Fensom AH; Bobrow M
    J Med Genet; 1992 Aug; 29(8):563-7. PubMed ID: 1387685
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Specificity and sensitivity of hexosaminidase assays and DNA analysis for the detection of Tay-Sachs disease gene carriers among Ashkenazic Jews.
    Fernandes MJ; Kaplan F; Clow CL; Hechtman P; Scriver CR
    Genet Epidemiol; 1992; 9(3):169-75. PubMed ID: 1387862
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Heterozygosity for Tay-Sachs and Sandhoff diseases in non-Jewish Americans with ancestry from Ireland, Great Britain, or Italy.
    Branda KJ; Tomczak J; Natowicz MR
    Genet Test; 2004; 8(2):174-80. PubMed ID: 15345116
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Carrier screening for cystic fibrosis, Gaucher disease, and Tay-Sachs disease in the Ashkenazi Jewish population: the first 1000 cases at New York University Medical Center, New York, NY.
    Kronn D; Jansen V; Ostrer H
    Arch Intern Med; 1998 Apr; 158(7):777-81. PubMed ID: 9554684
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel mutation in the HEXA gene specific to Tay-Sachs disease carriers of Jewish Iraqi origin.
    Karpati M; Peleg L; Gazit E; Akstein E; Goldman B
    Clin Genet; 2000 May; 57(5):398-400. PubMed ID: 10852376
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.